Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

Market Cap	3.15B +21.7%
Revenue (ttm)	914.65M -12.0%
Net Income	27.83M -30.1%
EPS	0.09 -30.0%
Shares Out	303.35M
PE Ratio	113.07
Forward PE	n/a
Dividend	0.04 (0.39%)
Ex-Dividend Date	Sep 24, 2025

Volume	12,628,500
Average Volume	10,993,675
Open	10.02
Previous Close	10.25
Day's Range	10.02 - 10.39
52-Week Range	7.83 - 12.90
Beta	0.61
RSI	62.14
Earnings Date	Apr 3, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It also engages in the cultivation, processing, and sale of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 634
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300534

Financial Performance

In 2024, SHE:300534's revenue was 1.04 billion, a decrease of -3.79% compared to the previous year's 1.08 billion. Earnings were 25.80 million, a decrease of -58.14%.